glp 1 histamine Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential Could GLP-1 Medications Be a

Back Marso, SP, Daniels, GH, Brown-Frandsen, K, et al (28 July 2016) 'Liraglutide and cardiovascular outcomes in type 2 diabetes', New England Journal of Medicine , 375/4, 311-22

Therapeutic potential of foldamers: from chemical biology tools to drug candidates

This means excess glucose gets excreted in the urine, which is how these medications lower blood sugar

Amplifying the efforts of primary care providers (PCPs) in the time between visits with a comprehensive behavior change-backed program

A systematic review of the effects of maternal obesity on neonatal outcomes in women with gestational diabetes

Any promotional activity, including so-called awareness campaigns, that functions as a surrogate advertisement for prescription-only drugs shall be viewed seriously and may be treated as irrational or misleading marketing practice, stated Dr Rajeev Singh Raghuvanshi, Drugs Controller General of India